Purpose: Early detection of risky behaviors involving prescription opioids can assist prescribers in implementing safer prescribing. Patient-to-prescriber travel patterns may indicate potential opioid misuse. We introduce doctor hopping, patients bypassing nearby prescribers in favor of more distant ones, as a new spatial estimation of potentially risky behavior, and compare with traditional doctor shopping metrics.
| INTRODUCTION
Between 2015 and 2016, enough opioids were dispensed to Arkansas recipients for every man, woman, and child in the state to take more than 2000 morphine milligram equivalents (MMEs). The Opioid Epidemic is a major health crisis in the United States with over 42 000 deaths related to opioids in 2016 alone. 1 In fact, the number of opioid-related deaths has surpassed fatalities related to motor vehicle accidents 2 that were 37 461 in 2016. Prescription opioids play an important role in the ongoing Opioid Epidemic in the United States;
the incidence of heroin use is 19 times higher among patients with prior nonmedical opioid use. 3 Furthermore, a qualitative study with young, intravenous drug users found that almost all (86%) heroin users had used prescription opioids prior to their heroin use, and in most cases, opioids were obtained from family, friends, or personal prescriptions. 4 It is, therefore, imperative that detection of nonmedical use of prescription opioids be identified early.
With prescription claims data, one method of detecting nonmedical use of prescription opioids is identifying doctor shopping behavior, traditionally characterized as patients seeking out multiple prescribers and multiple dispensers in order to obtain larger amounts of opioids. [5] [6] [7] Patient-to-prescriber travel patterns may also be a useful indicator of potential misuse. 8 A national study of opioid doctor shopping behavior found shoppers traveled greater distances than nonshoppers and more often crossed state borders to fill prescriptions. 9 A study in Maine found increasing patient-to-prescriber travel distance was associated with increased relative odds of a prescriber being subject to severe disciplinary actions by the state medical board. 10 Here we introduce doctor hopping behavior, characterized by above average patient-to-prescriber travel distances and patients bypassing nearby prescribers in favor of more distant ones. Distinct from doctor shopping, doctor hopping focuses on patient travel patterns, and provides an early-warning indicator of high-risk behavior.
For a recipient to be identified as engaging in doctor shopping, they would need to have already received opioid prescriptions from several prescribers and pharmacies. In contrast, doctor hopping can be identified after only two prescriptions. 
KEY POINTS
• Spatial analyses of patient travel patterns offer opportunities for early-warning indicators of potentially risky opioid use behavior.
• We introduce a new indicator called doctor hopping based on patient-to-prescriber travel patterns.
• Doctor hopping in Arkansas is associated with increased odds of high-risk opioid use.
• Doctor hopping is more common in rural areas, while doctor shopping is more common in urban areas.
• We recommend PDMP vendors incorporate spatial analyses into their systems. 19 CDC guidelines urge clinicians to reconsider prescribing more than 90 MME per day, because the risks of such high-dose prescriptions often outweigh the benefits. 15 Temporal overlap with other centrally acting medications has been previously shown to increase the risk of opioid overdose and CDC guidelines recommend such overlap be avoided. 15, [20] [21] [22] [23] In our study, temporal overlap in prescriptions was determined according to dispensed days' supply, under the conservative assumption that all prescribed substances were used within the prescribed days' supply.
We chose not to include a lag/cushion time to the overlap determination to avoid artificially inflating the number of recipients engaging in high-risk use. Thus, if a 30-day supply of opioids was followed by a SMR prescription to the same recipient more than or equal to 31 days later, no overlap was indicated.
To model travel distances from recipient zip codes to prescriber zip codes, an Origin-Destination Cost Matrix was calculated in a geographic information system (GIS) using road network distances. Origins were all zip code centroids in Arkansas (n = 701) and Destinations included Arkansas zip codes and all zip codes within 200 km of the Arkansas border (n = 2932) to include prescriptions received outside of the state. A distance of 200 km was determined to be sufficient to allow recipients from any zip code in Arkansas to reach an urban area, where more than 90% of prescribers practice. 24 We used pre- Health. 25, 26 We used a floating threshold for travel distance that was unique for each zip code by calculating the distance from each zip code to the nearest neighboring urban zip code. Only patient-to-prescriber travel exceeding this threshold was considered as potential doctor hopping. For each opioid prescription the number of prescribers hopped was counted, then ranked compared with others from the same zip code. Only those in the top 1% that also exceeded the travel threshold were considered instances of doctor hopping.
Thresholds used for identifying doctor shopping behavior vary greatly between studies but generally include prescriptions from more than one prescriber and/or filled at more than one pharmacy within a given window of time, anywhere from one to 18 months. 5, 8, 9, 27 Some use highly restrictive criteria (eg, six or more prescribers and six or more pharmacies within 3 months) that benefit from specificity but likely underestimate the extent of the problem. 5 We examined a range of thresholds for doctor shopping behavior, ranging from four or more prescribers and four or more pharmacies within a 90-day period (4 × 4 × 90), to six or more prescribers and six or more pharmacies within 90 days (6 × 6 × 90). We compared results between different thresholds, as well as when used in combination with the doctor hopping metric.
We calculated odds ratios to determine how engaging in doctor hopping and/or doctor shopping was associated with the likelihood of high-risk use among opioid recipients, using the Woolf method with We mapped the rate of recipients engaging in doctor hopping per 10 000 people at the zip code scale (see Figure 2 ). Rates were low in the southwest corner of the state and generally high in the southeast corner. Urban areas tended to have low to moderate rates of doctor hopping, while rural areas ranged from low to high rates.
Nearly a quarter of all recipients (24.4%) exhibited some form of high-risk use one or more times between 2015 and 2016. Table 2 lists the odds ratio results for patients engaging in doctor hopping, doctor shopping, or both on specific high-risk uses. Doctor hopping was associated with increased odds of high-risk use (OR: 3.29) with odds ratios for specific uses ranging from 2.72 to 3.24. Odds ratios for doctor shopping and high-risk use were much higher, ranging from 11.48 to 19.06.
The odds ratios for both doctor hopping and doctor shopping with 
| DISCUSSION
Both doctor hopping and doctor shopping were quite variable across the state. This variability is indicative of the importance geographic location plays in obtaining and using opioids. Beyond geographic location alone, doctor hopping was shown to be associated with rurality. While small population sizes in rural areas may make some rates at the zip code scale unreliable, overall trends (shown in Oklahoma) are also largely rural. It is imperative that rurality be thoroughly explored as a possible contributor to the opioid epidemic and high levels of opioid prescribing in many rural states. Although recipients from rural zip codes generally must travel farther than recipients from urban zip codes in order to obtain prescriptions, our use of a floating travel distance threshold was designed to ensure rural recipients were not identified as doctor hopping solely due to their rurality.
In addition to urban/rural differences, there appears to be a regional pattern of doctor hopping within Arkansas, with some clustering of low rates in the southwest corner of the state and more diffuse clustering of high rates in the southeast corner, both predominantly rural areas. The low rates in the southwest corner are notable considering the high percentage of opioid recipients from that region who travel to Texas for prescriptions; in some zip codes near the border, nearly two-thirds of recipients travel out-of-state. The low rates of doctor hopping in this area seem to demonstrate that rurality and The number of recipients engaging in both doctor hopping and shopping was only about 9% to 16% of those engaging in doctor shopping only, indicating the two metrics capture largely distinct populations of high-risk opioid recipients (see Table 1 ). 
30
A limitation of the current study was the lack of specialty information for the prescribers or any diagnosis information for the recipients.
For example, patients traveling to specialists, including cancer patients and those receiving opioids for end-of-life palliative care could not be evaluated separately from other recipients in the current study. Prescriber specialty information is not included in the data extracts from the AR PDMP vendor and is therefore not available to researchers.
Just as not all "doctor shoppers" are engaged in diversion or misuse, many opioid recipients will have legitimate reasons to visit prescribers far from their zip code of residence. Doctor hopping is not intended as confirmation of inappropriate behavior but merely as an indicator of potentially risky behavior. Importantly, these analyses have shown that doctor hopping is positively associated with high-risk opioid use.
High-risk opioid use has been shown to increase the risk of overdoses from opioids. 22 Each of the high-risk opioid use measures evaluated in this study showed an increased association with doctor hopping, ranging from 272% to 324% higher odds. Therefore, the measure demonstrated here for doctor hopping appears to be a viable instrument for assessing the potential for high-risk opioid use, particularly when used in combination with doctor shopping metrics. Further, because the addition of doctor hopping to doctor shopping metrics strengthens the association with high-risk use even with less restrictive shopping criteria, it has the potential to be an early-warning indicator of risk that does not require as many prior prescriptions before risky behavior is identified. More work needs to be done to determine if doctor hopping, as presently defined, is generalizable to other states. We anticipate minor modifications (such as the distance beyond state boundaries included in the analysis) may be necessary, but the use of floating thresholds and percentiles should be easily transferrable.
| CONCLUSION
Doctor hopping (defined as both exceeding a threshold distance of travel from home zip code to prescriber zip code and being in the upper percentile of recipients from the same zip code in terms of the number of prescribers hopped) is positively associated with highrisk opioid use and largely distinct from doctor shopping metrics. Clinicians should be made aware of doctor hopping behavior so they can closely evaluate those patients, preferably before writing additional prescriptions. We recommend PDMP vendors incorporate spatial analyses such as doctor hopping into their systems, in connection with doctor shopping metrics and other automatable algorithms to assist prescribers in implementing safer opioid prescribing.
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